The addition of nivolumab to neoadjuvant chemotherapy significantly increased pathologic complete response among certain patients with breast cancer, according to findings published in Nature Medicine ...

Harrow has announced a new initiative, VEVYE Access for All, in hopes of removing obstacles to dry eye therapy via a partnership with PhilRx, a national mail-order pharmacy partner ... are already ...

--(BUSINESS WIRE)--Cadrenal Therapeutics, Inc. (Nasdaq ... and provided a business update and highlights of the path forward for the clinical advancement of tecarfarin. “2024 for Cadrenal was a year ...

Armata is a clinical-stage biotechnology company focused on the development of pathogen-specific bacteriophage therapeutics for the treatment of antibiotic-resistant and difficult-to-treat ...

SEOUL, South Korea--(BUSINESS WIRE)--Hudson Therapeutics, the U.S. subsidiary of Shaperon, announced today that Shaperon will commence the Phase 2b Part 2 of its clinical trial for NuGel ...

The clinical trials will be performed in three different countries, Italy, Australia and Germany. Part of the investment round will be invested in Italy and allocated to the activities of the newly ...

March 10 (Reuters) - India's Sun Pharmaceutical Industries (SUN.NS), opens new tab said on Monday it will acquire Checkpoint Therapeutics (CKPT.O), opens new tab, a U.S.-based immunotherapy and ...

Marcus Evans is proud to announce the Evolution Summit 2025, an exclusive, invitation-only event that will unite leading clinical trial executives with innovative suppliers and solution providers in ...

The FDA granted RMAT Designation for RPESC-RPE-4W, highlighting its potential as a novel treatment for dry AMD. Clinical data from the Phase 1/2a clinical trial evaluating RPESC-RPE-4W was presented ...

UT Southwestern Medical Center of Dallas, Cleveland-based Case Western Reserve University and Houston-based University of Texas MD Anderson Cancer Center, and was sponsored by Plus Therapeutics.

HONG KONG SAR, HONG KONG, March 7, 2025 /EINPresswire.com/ -- Liberyx Therapeutics, a clinical-stage biopharmaceutical company developing safe, effective, and patient ...

Lady Gaga's seventh studio solo album, "MAYHEM," is here. Ahead of the release of the highly anticipated new project, the Grammy award-winning singer sat down with "Good Morning America" co-anchor ...